The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kuznetsova Iu.N.

Ural'skiĭ nauchno-issledovatel'skiĭ institut dermatovenerologii i immunopatologii, Ekaterinburg

Zil'berberg N.V.

State federal facility "Ural Research Institute of Dermatovenerology and Immunopathology", Ekaterinburg

Efficacy of combined therapy of manifestations of papilloma virus infection in the urogenital tract

Authors:

Kuznetsova Iu.N., Zil'berberg N.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2010;8(5): 70‑75

Read: 1005 times

Download PDF (RU)
Contact the author
Table of contents

EFFICACY OF COMBINED THERAPY OF MANIFESTATIONS OF PAPILLOMA VIRUS INFECTION IN THE UROGENITAL TRACT
EFFICACY OF COMBINED THERAPY OF MANIFESTATIONS OF PAPILLOMA VIRUS INFECTION IN THE UROGENITAL TRACT

To cite this article:

Kuznetsova IuN, Zil'berberg NV. Efficacy of combined therapy of manifestations of papilloma virus infection in the urogenital tract. Russian Journal of Clinical Dermatology and Venereology. 2010;8(5):70‑75. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Modern methods of treatment of latent form of HPV infe­ction: clinical obse­rvation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):425-429
Expe­rience of using ribo­ciclib in the therapy of meta­static breast cancer in a regional onco­logical dispensary. P.A. Herzen Journal of Onco­logy. 2025;(3):89-93
Resu­lts of the inte­rnational multicenter randomized, double-blind, placebo-controlled clinical trial for the evaluation of the effi­cacy and safety of the sequential therapy with ethy­lmethylhydroxypyridine succinate in patients in the acute and early reco­very periods of ischemic stroke (MIR). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8-2):40-53
Effe­ctiveness and tole­rability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):90-98
Resu­lts of an open-label, randomized, multicenter, comparative study of clinical effi­cacy and safety of Pulmibud drug and Pulmicort drug in patients with partially controlled and unco­ntrolled persistent bronchial asthma. Journal of Respiratory Medi­cine. 2025;(3):33-38
Asso­ciations of poly­morphic variants of CYP2C19*2, *17 with effe­ctiveness and safety of sertraline in adolescents with a depressive episode and suicidal tendencies. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):12-20
Onasemnogene abeparvovec gene replacement therapy for spinal muscular atro­phy in children: a Moscow expe­rience. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10-2):103-113
Clinical effi­cacy of dupi­lumab mono­clonal anti­body in the treatment of recu­rrent severe chro­nic rhinosinusitis with nasal polyps without bronchial asthma. Russian Rhinology. 2025;(4):32-37
Spectrum of tole­rability and safety of the use of brain—computer inte­rfaces with biofeedback in cognitive reha­bilitation after a stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):86-93
An open-label obse­rvational study of the effi­cacy and tole­rability of rapi­dly dissolving forms of aceclofenac and nime­sulide for oral use in the treatment of patients with acute non-specific low back pain (ASTRA study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):141-147
Abstract:

Keywords:

papilloma virus infection
urogenital tract
methods of therapy
clinical efficiency
tolerability
safety
groprinosin (inosine pranobex)

Authors:

Kuznetsova Iu.N.

Ural'skiĭ nauchno-issledovatel'skiĭ institut dermatovenerologii i immunopatologii, Ekaterinburg

Zil'berberg N.V.

State federal facility "Ural Research Institute of Dermatovenerology and Immunopathology", Ekaterinburg

Close metadata

References:

  1. WHO reports 2004-2008, vklyuchitel'no "Human papillomavirus infection and cervical cancer, 2004". http://www.who.int/healthinfo/statistics/bodprojections2030/ en/index.html
  2. Statisticheskie materialy "Zabolevaemost', resursy i deyatel'nost' kozhno-venerologicheskikh uchrezhdenii (2008-2009 gg.)" 2010;119.
  3. Klinicheskie rekomendatsii. Dermatovenerologiya. Pod red. A.A. Kubanovoi. M: DEKS-Press 2008;365.
  4. Centers for Disease Control and Prevention. STD Guidelines 2006. MMWR 2006;55:97.
  5. Gomberg M.A., Solov'ev M.A. Rekomendatsii patsientam s papillomavirusnoi infektsiei pri otsutstvii ee klinicheskikh proyavlenii. Med Sovet 2009;3:12-18.
  6. et al. CDC reports 2006-2008, vklyuchitel'no "Sexually Transmitted Diseases Treatment Guidelines, 2006". MMWR 2006;55:RR-11:62-67. http://www.cdc.gov/std
  7. Fox P.A., Tung M.Y. Human papillomavirus: burden of illness and treatment cost considerations. Am J Clin Dermatol 2005;6:6:365-381.
  8. Kodner C.M., Nasraty S. Management of genital warts. Am Fam Phys 2004;70:12:2335-2342.
  9. New Zealand Guidelines Group. Guidelines for the Management of Genital HPV in Australia and New Zealand 2007.
  10. WHO reports 2004-2008, vklyuchitel'no "Human papillomavirus infection and cervical cancer, 2004". http://www.who.int/healthinfo/statistics/bodprojections2030/ en/index.html
  11. Wiley D.J., Douglas J., Beutner K. et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002;35:Suppl 2:S210-S224.
  12. Mynbaev O.A., Eliseeva M.Yu., Doorbar Dzh., Manukhin I.B. Epidemiologiya, molekulyarnaya biologiya, patofiziologiya i printsipy immunoterapii papillomavirusnoi infektsii. Vopr ginekol akush i perinatol 2009;3:69-79.
  13. Kostava M.N., Prilepskaya V.N. Vozmozhnosti terapii papillomavirusnoi infektsii. Rus med zhurn 2009;17:1:16-19.
  14. Dolgushina V.F., Akhmatova A.N., Berenda M.A. Effektivnost' izoprinozina v lechenii khronicheskogo tservitsita, assotsiirovannogo s papillomavirusnoi infektsiei. Farmateka 2009;14:73-76.
  15. Zabelev A.V., Dolmatova O.K., Sivokoneva E.N. i dr. Rezul'taty kol'poskopicheskogo skrininga i opyt primeneniya Izoprinozina v lechenii papillomavirusnykh porazhenii sheiki matki. Farmateka 2005;3:72-75.
  16. Kedrova A.G., Podistov Yu.I., Kuznetsov V.V. i dr. Rol' protivovirusnoi terapii v kompleksnom lechenii bol'nykh epitelial'nymi displaziyami i preinvazivnym rakom sheiki matki. Ginekologiya 2005;7:170-174.
  17. Linask L.I., Grigor'eva E.E. Opyt primeneniya Izoprinozina pri zabolevaniyakh sheiki matki na fone papillomavirusnoi infektsii u podrostkov i molodykh zhenshchin. Rus med zhurn 2008;16:1221-1225.
  18. Potapov V.A., Demchenko T.V., Strel'tsova T.R. i dr. Kliniko-laboratornaya otsenka effektivnosti Izoprinozina v lechenii papillomavirusnoi infektsii, assotsiirovannoi s tservikal'noi intraepitelial'noi neoplaziei. Reprod zdor zhenshchin 2006;1:134-135.
  19. Prilepskaya V.N., Rogovskaya S.I. Vozmozhnosti Izoprinozina v lechenii khronicheskikh tservitsitov i vaginitov. Rus med zhurn 2008;1:5-9.
  20. Davidson-Parker J., Dinsmore W., Khan M.H. et al. Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study. Genitourin Med 1988;64:6:383-386.
  21. Mohanty K.C., Scott C.S. Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study. Genitourin Med 1986;62:5:352-355.
  22. CICSG. Condylomata International Collaborative Study Group. Randomized placebo-controlled double-blind combined therapy with laser surgery and systemic interferon-alpha 2a in the treatment of anogenital condylomata acuminatum. J Infect Dis 1993;167:824-829.
  23. Ho G.Y. et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:7:423-428.
  24. Gross G., Rogozinski T., Schofer H. et al. Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: results of a placebo-controlled double-blind study in 120 patients. Dermatology 1998;196:330-334.
  25. Cao Y., Zhao J., Lei Z. et al. Local accumulation of FOXP3+ regulatory T cells: evidence for an immuneevasion mechanism in patients with large condylomata acuminata. J Immunol 2008;180:11:7681-7686.
  26. Resta L., Troia M., Russo S. et al. Variations of lymphocyte sub-populations in vulvar condylomata during therapy with beta-interferon. Eur J Gynaecol Oncol 1992;13:5:440.
  27. Todd R.W., Roberts S., Mann C.H. et al. Human papillomavirus (HPV) type 16-specific CD8+ T cell responses in women with high grade vulvar intraepithelial neoplasia. Int J Cancer 2004;108:6:857-862.
  28. Handley J.M., Maw R.D., Horner T. et al. A placebo controlled observer blind immunocytochemical and histologic study of epithelium adjacent to anogenital warts in patients treated with systemic interferon alpha in combination with cryotherapy or cryotherapy alone. Genitourin Med 1992;68:100-105.
  29. Eliseeva M.Yu., Mynbaev O.A. Vspomogatel'naya immunoterapiya VPCh-assotsiirovannykh porazhenii slizistykh obolochek i kozhi urogenital'noi i perianal'noi lokalizatsii (Sistematicheskii obzor literatury i meta-analiz primeneniya Inozina Pranobeksa). Ginekologiya 2009;5:22-33.
  30. Mynbaev O.A., Eliseeva M.Yu., Masikhi K.N. i dr. Groprinosin - vysokoeffektivnyi immunostimulyator dlya "trudnykh" patsientov s narusheniyami v immunnoi sisteme. Trudnyi patsient 2009;7:27-34.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.